Abstract
We included acute ischemic stroke (AIS) patients who received recombinant tissue plasminogen activator (rt-PA) at three stroke centers via either interhospital transfer or direct presentation and compared the clinical outcomes and time metrics to analyze the impact of interhospital transfer on intravenous thrombolysis (IVT). We retrospectively enrolled patients with AIS admitted to three stroke centers from October 1, 2016, to June 1, 2018. Patients treated with rt-PA were classified into the transfer and direct groups. We collected the patients’ general information and time points. Statistical analyses were conducted to examine differences in the clinical outcomes and time metrics between the two groups. A total of 326 patients were enrolled, including 84 patients in the transfer group and 242 in the direct group. The transfer group had a longer onset-to-door time (OTD) (124.5 ± 50.6 min versus 83.2 ± 47.2 min, P < 0.01) but a shorter door-to-needle time (DNT) (53.0 ± 26.3 min versus 81.5 ± 31.1 min, P < 0.01), and the stroke onset-to-needle time was 177.4 ± 51.0 min versus 164.7 ± 53.3 min (P = 0.057). Compared with the direct group, the transfer group achieved similar modified Rankin scale (mRS) 0–2 outcomes (59.5% versus 58.7%, P = 0.768). Interhospital transfer was not an independent risk factor associated with a poor outcome at 90 days. In three Chinese municipal stroke centers, patients with an AIS referral have a longer OTD but a shorter DNT. DNTs of municipal hospitals were far longer than the current international standard, and their improvement is an important task.
Similar content being viewed by others
References
Feigin VL, Krishnamurthi RV, Parmar P, Norrving B, Mensah GA, Bennett DA, Barker-Collo S, Moran AE, Sacco RL, Truelsen T, Davis S, Pandian JD, Naghavi M, Forouzanfar MH, Nguyen G, Johnson CO, Vos T, Meretoja A, Murray CJ, Roth GA (2015) Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990–2013: the GBD 2013 Study. Neuroepidemiology 45(3):161–176. https://doi.org/10.1159/000441085
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333(24):1581–1587. https://doi.org/10.1056/nejm199512143332401
Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359(13):1317–1329. https://doi.org/10.1056/nejmoa0804656
Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW Jr, Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H (2013) Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44(3):870–947. https://doi.org/10.1161/STR.0b013e318284056a
Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W, Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G (2010) Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet (London, England) 375(9727):1695–1703. https://doi.org/10.1016/s0140-6736(10)60491-6
Saver JL, Fonarow GC, Smith EE, Reeves MJ, Grau-Sepulveda MV, Pan W, Olson DM, Hernandez AF, Peterson ED, Schwamm LH (2013) Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA 309(23):2480–2488. https://doi.org/10.1001/jama.2013.6959
Kim DH, Bae HJ, Han MK, Kim BJ, Park SS, Park TH, Lee KB, Kang K, Park JM, Ko Y, Lee SJ, Choi JC, Kim JT, Cho KH, Hong KS, Cho YJ, Kim DE, Lee J, Lee J, Oh MS, Yu KH, Lee BC, Nah HW, Cha JK (2016) Direct admission to stroke centers reduces treatment delay and improves clinical outcome after intravenous thrombolysis. J Clin Neurosci 27:74–79. https://doi.org/10.1016/j.jocn.2015.06.038
Froehler MT, Saver JL, Zaidat OO, Jahan R, Aziz-Sultan MA, Klucznik RP, Haussen DC, Hellinger FR Jr, Yavagal DR, Yao TL, Liebeskind DS, Jadhav AP, Gupta R, Hassan AE, Martin CO, Bozorgchami H, Kaushal R, Nogueira RG, Gandhi RH, Peterson EC, Dashti SR, Given CA 2nd, Mehta BP, Deshmukh V, Starkman S, Linfante I, McPherson SH, Kvamme P, Grobelny TJ, Hussain MS, Thacker I, Vora N, Chen PR, Monteith SJ, Ecker RD, Schirmer CM, Sauvageau E, Abou-Chebl A, Derdeyn CP, Maidan L, Badruddin A, Siddiqui AH, Dumont TM, Alhajeri A, Taqi MA, Asi K, Carpenter J, Boulos A, Jindal G, Puri AS, Chitale R, Deshaies EM, Robinson DH, Kallmes DF, Baxter BW, Jumaa MA, Sunenshine P, Majjhoo A, English JD, Suzuki S, Fessler RD, Delgado Almandoz JE, Martin JC, Mueller-Kronast NH (2017) Interhospital transfer before thrombectomy is associated with delayed treatment and worse outcome in the STRATIS registry (systematic evaluation of patients treated with neurothrombectomy devices for acute ischemic stroke). Circulation 136(24):2311–2321. https://doi.org/10.1161/circulationaha.117.028920
Prabhakaran S, Ward E, John S, Lopes DK, Chen M, Temes RE, Mohammad Y, Lee VH, Bleck TP (2011) Transfer delay is a major factor limiting the use of intra-arterial treatment in acute ischemic stroke. Stroke 42(6):1626–1630. https://doi.org/10.1161/strokeaha.110.609750
Huang Q, Ma QF, Jia JP, Feng J, Cheng WY, Chang H, Wu J (2015) Referral leads to prehospital delay of intravenous thrombolysis for acute ischemic stroke in Beijing. Int J Stroke 10(7):E80–E81. https://doi.org/10.1111/ijs.12568
Chinese Society of Neurology, Neurovascular Intervention Group of Chinese Society of Neurology (2015) Chinese guidelines for the endovascular treatment of acute ischemic stroke. Chin J Neurol 48(5):356–361. https://doi.org/10.3760/cma.j.issn.1006-7876.2015.05.002
Chinese Society of Neurology, Chinese Stroke Society (2015) Chinese guidelines for diagnosis and management of acute ischemic stroke 2014. Chin J Neurol 48(4):246–257. https://doi.org/10.3760/cma.j.issn.1006-7876.2015.04.002
National Health and Family Planning Commission Stroke Prevention Protect Committee (2016) Chinese guidelines for intravenous thrombolysis in acute ischemic stroke[S]
Huang Q, Ma QF, Feng J, Cheng WY, Jia JP, Song HQ, Chang H, Wu J (2015) Factors associated with in-hospital delay in intravenous thrombolysis for acute ischemic stroke: lessons from China. PLoS ONE 10(11):e0143145. https://doi.org/10.1371/journal.pone.0143145
Liu Z, Zhao Y, Liu D, Guo ZN, Jin H, Sun X, Yang Y, Sun H, Yan X (2018) Effects of nursing quality improvement on thrombolytic therapy for acute ischemic stroke. Front Neurol 9:1025. https://doi.org/10.3389/fneur.2018.01025
Mendelson SJ, Courtney DM, Gordon EJ, Thomas LF, Holl JL, Prabhakaran S (2018) National practice patterns of obtaining informed consent for stroke thrombolysis. Stroke 49(3):765–767. https://doi.org/10.1161/strokeaha.117.020474
He AJ, Qian J (2016) Explaining medical disputes in Chinese public hospitals: the doctor–patient relationship and its implications for health policy reforms. Health Econ Policy Law 11(4):359–378. https://doi.org/10.1017/s1744133116000128
Huang P, Khor GT, Chen CH, Lin RT, Liu CK (2011) Eligibility and rate of treatment for recombinant tissue plasminogen activator in acute ischemic stroke using different criteria. Acad Emerg Med 18(3):273–278. https://doi.org/10.1111/j.1553-2712.2011.01006.x
Saver JL, Goyal M, van der Lugt A, Menon BK, Majoie CB, Dippel DW, Campbell BC, Nogueira RG, Demchuk AM, Tomasello A, Cardona P, Devlin TG, Frei DF, du Mesnil de Rochemont R, Berkhemer OA, Jovin TG, Siddiqui AH, van Zwam WH, Davis SM, Castano C, Sapkota BL, Fransen PS, Molina C, van Oostenbrugge RJ, Chamorro A, Lingsma H, Silver FL, Donnan GA, Shuaib A, Brown S, Stouch B, Mitchell PJ, Davalos A, Roos YB, Hill MD (2016) Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA 316(12):1279–1288. https://doi.org/10.1001/jama.2016.13647
Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S (2004) Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet (London, England) 363(9411):768–774. https://doi.org/10.1016/s0140-6736(04)15692-4
de la Ossa NP, Sanchez-Ojanguren J, Palomeras E, Millan M, Arenillas JF, Dorado L, Guerrero C, Abilleira S, Davalos A (2008) Influence of the stroke code activation source on the outcome of acute ischemic stroke patients. Neurology 70(15):1238–1243. https://doi.org/10.1212/01.wnl.0000291008.63002.a5
Perez de la Ossa N, Millan M, Arenillas JF, Sanchez-Ojanguren J, Palomeras E, Dorado L, Guerrero C, Davalos A (2009) Influence of direct admission to Comprehensive Stroke Centers on the outcome of acute stroke patients treated with intravenous thrombolysis. J Neurol 256(8):1270–1276. https://doi.org/10.1007/s00415-009-5113-7
Kim DH, Cha JK, Park HS, Choi JH, Kang MJ, Huh JT (2014) Direct access to a hospital offering intravenous thrombolysis therapy improves functional outcome of acute ischemic stroke patients. J Clin Neurosci 21(8):1428–1432. https://doi.org/10.1016/j.jocn.2014.03.014
Fargen KM, Jauch E, Khatri P, Baxter B, Schirmer CM, Turk AS, Mocco J (2015) Needed dialog: regionalization of stroke systems of care along the trauma model. Stroke 46(6):1719–1726. https://doi.org/10.1161/strokeaha.114.008167
Acknowledgments
None.
Funding
This research received no external funding.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ding, Y., Ji, Z., Ma, L. et al. Interhospital transfer on intravenous thrombolysis in patients with acute ischemic stroke in three chinese municipal stroke centers. J Thromb Thrombolysis 48, 580–586 (2019). https://doi.org/10.1007/s11239-019-01912-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-019-01912-y